Loading company…
Riskpilot
← Back to search
Sign in
Get full access
MJJ Biotech A/S
A/S
Dissolved
CVR 43227831
C.F. Tietgens Boulevard 30A, st. th
Research and experimental development on natural sciences and engineering · NACE 7210
Est. 2022
4 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
DKK 2,6M
-66% vs 2023
EBITDA margin
11.2%
-54% vs 2023
Equity ratio
-409.2%
Financial strength
Net profit 2024
DKK -2,5M
-1741% vs 2023
EBITDA — year on year
DKK millions
1M
1M
1M
0M
0M
1M
2022
1M
0%
2023
0M
-100%
2024
Key figures
Annual report 2024
Revenue
DKK 2,6M
-66%
EBITDA
DKK 287K
-54%
Net profit
DKK -2,5M
-1741%
Total assets
DKK 453K
-91%
Equity
DKK -1,9M
-371%
Employees
4
—
Company information
Legal name
MJJ Biotech A/S
CVR number
43227831
Legal form
Aktieselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
22. april 2022
Share capital
DKK 400.000
Employees
4 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren eller af den samlede bestyrelse.
Contact
Address
C.F. Tietgens Boulevard 30A, st. th
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Research and experimental development on natural sciences and engineering
Companies in Odense
All Denmark companies
Revenue
DKK millions
0M
2M
5M
7M
9M
2M
2022
8M
2023
3M
2024
EBITDA
DKK millions
0M
0M
1M
1M
1M
1M
2022
1M
2023
0M
2024
Income statement
DKK thousands
Item
2022
2023
2024
Revenue
1.640
7.554
2.572
Staff expenses
-1.060
-6.926
-2.285
EBITDA
580
628
287
Depreciation & amort.
-31
-807
-2.913
EBIT
549
-179
-2.626
Net financials
-1
3
1
Profit before tax
548
-176
-2.625
Tax
128
-38
-89
Net profit
420
-138
-2.536
Balance sheet
DKK thousands
Item
2022
2023
2024
Total assets
6.042
4.836
453
Equity
820
683
-1.853
Long-term debt
0
0
0
Short-term debt
5.094
4.065
2.306
Total debt
5.094
4.065
2.306
Financial ratios
5-year trend
EBITDA margin
11.2%
This company
15.8%
Market median
-29% vs market
2022
2024
Equity ratio
-409.2%
This company
38.2%
Market median
-1171% vs market
2022
2024
Return on equity
-253568100.0%
This company
18.4%
Market median
-1378087600% vs market
2022
2024
Net profit margin
-98.6%
This company
8.1%
Market median
-1317% vs market
2022
2024
Asset turnover
5.68×
This company
1.12×
Market median
+407% vs market
2022
2024
Debt / equity
1.24×
This company
0.62×
Market median
-100% vs market
2022
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-04-22 – 2022-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Former (1)
HT
Hans Thorleif Møller
Management
Management
2022 – 2025
Board of directors
Non-executive oversight
Name
Role
Member since
Former (2)
ZJ
Zhai JiaJie
Chairman
2022 – 2026
QP
Qi Peng
Board of Directors
2022 – 2026
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Guandong Maijinjia Biotechnologies Co., Ltd
Individual
100%
100%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of MJJ Biotech A/S also hold positions in
0
other companies.
Person
Role here
Other companies
Hans Thorleif Møller
Management
0 companies
Zhai JiaJie
Chairman
0 companies
Qi Peng
Board of Directors
0 companies